These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 37858131)
1. Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment. Yang M; Su Y; Xu K; Zheng H; Yuan Q; Cai Y; Aihaiti Y; Xu P J Orthop Surg Res; 2023 Oct; 18(1):787. PubMed ID: 37858131 [TBL] [Abstract][Full Text] [Related]
2. Develop a Novel Signature to Predict the Survival and Affect the Immune Microenvironment of Osteosarcoma Patients: Anoikis-Related Genes. Yang M; Su Y; Xu K; Zheng H; Cai Y; Wen P; Yang Z; Liu L; Xu P J Immunol Res; 2024; 2024():6595252. PubMed ID: 39431237 [TBL] [Abstract][Full Text] [Related]
3. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA. Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P Front Immunol; 2022; 13():919231. PubMed ID: 35967366 [TBL] [Abstract][Full Text] [Related]
4. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma. Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y Front Immunol; 2021; 12():806189. PubMed ID: 35095893 [TBL] [Abstract][Full Text] [Related]
5. Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma. Liu B; Liu Z; Feng C; Li C; Zhang H; Li Z; Tu C; He S Front Endocrinol (Lausanne); 2022; 13():987942. PubMed ID: 36313774 [TBL] [Abstract][Full Text] [Related]
6. Verification of Ferroptosis Subcluster-Associated Genes Related to Osteosarcoma and Exploration of Immune Targeted Therapy. Jiang M; Jike Y; Gan F; Li J; Hu Y; Xie M; Liu K; Qin W; Bo Z Oxid Med Cell Longev; 2022; 2022():9942014. PubMed ID: 36211822 [TBL] [Abstract][Full Text] [Related]
7. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma. Lei T; Qian H; Lei P; Hu Y Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683 [TBL] [Abstract][Full Text] [Related]
8. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms. Li G; Lei J; Xu D; Yu W; Bai J; Wu G Sci Rep; 2023 Apr; 13(1):5770. PubMed ID: 37031292 [TBL] [Abstract][Full Text] [Related]
9. Identification of Ferroptosis-Associated Long Noncoding RNA Prognostic Model and Tumor Immune Microenvironment in Thyroid Cancer. Lin Y; Gan F; He X; Deng H; Li Y J Immunol Res; 2022; 2022():5893998. PubMed ID: 35915656 [TBL] [Abstract][Full Text] [Related]
10. Development of a Risk Model and Genotyping Patterns Based on Disulfidptosis-Related lncRNAs to Predict Prognosis and Immune Landscape in Osteosarcoma. Zhang K; Lu S; Jiang M; Zou X; Chen C; Lan Y; Zhao H; Ma R; Yan H Front Biosci (Landmark Ed); 2024 May; 29(5):193. PubMed ID: 38812298 [TBL] [Abstract][Full Text] [Related]
11. A five ferroptosis-related genes risk score for prognostic prediction of osteosarcoma. Ge Z; Song D Medicine (Baltimore); 2022 Dec; 101(50):e32083. PubMed ID: 36550843 [TBL] [Abstract][Full Text] [Related]
12. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma. Zhang X; Wen Z; Wang Q; Ren L; Zhao S Front Immunol; 2023; 14():1199869. PubMed ID: 37575253 [TBL] [Abstract][Full Text] [Related]
13. Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC. Li M; Zhang Y; Fan M; Ren H; Chen M; Shi P BMC Med Genomics; 2021 Dec; 14(1):286. PubMed ID: 34861872 [TBL] [Abstract][Full Text] [Related]
14. Integrated Identification and Immunotherapy Response Analysis of the Prognostic Signature Associated With m6A, Cuproptosis-Related, Ferroptosis-Related lncRNA in Endometrial Cancer. Qian Y; Chen H; Miao P; Ma R; Lu B; Hu C; Fan R; Xu B; Chen B Cancer Rep (Hoboken); 2024 Sep; 7(9):e70009. PubMed ID: 39324703 [TBL] [Abstract][Full Text] [Related]
15. Identification and validation of long noncoding RNA AC083900.1 and RP11-283C24.1 for prediction of progression of osteosarcoma. Huang L; Jin W; Bao Y; Zeng X; Zhang Y; Zhou J; Peng H Mutat Res; 2023; 827():111828. PubMed ID: 37437507 [TBL] [Abstract][Full Text] [Related]
16. Potential prognostic value of a eight ferroptosis-related lncRNAs model and the correlative immune activity in oral squamous cell carcinoma. Qiu L; Tao A; Liu F; Ge X; Li C BMC Genom Data; 2022 Nov; 23(1):80. PubMed ID: 36384476 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive investigation of tumor immune microenvironment and prognostic biomarkers in osteosarcoma through integrated bulk and single-cell transcriptomic analysis. Shi S; Zhang L; Guo X Front Immunol; 2024; 15():1424950. PubMed ID: 39108264 [TBL] [Abstract][Full Text] [Related]
18. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma. Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y Front Immunol; 2021; 12():719175. PubMed ID: 34603293 [TBL] [Abstract][Full Text] [Related]
19. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients. Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478 [TBL] [Abstract][Full Text] [Related]
20. Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma. Wei SY; Feng B; Bi M; Guo HY; Ning SW; Cui R BMC Med Genomics; 2022 Dec; 15(1):263. PubMed ID: 36528763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]